| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8815495 | Journal of Affective Disorders | 2018 | 76 Pages |
Abstract
The identification of accurate, reliable neuroimaging biomarkers of treatment response holds promise toward improving treatment outcomes and reducing burden of illness for patients with MDD. However, before these biomarkers can be translated into clinical practice, they will need to be replicated and validated in large, independent samples, and integrated with data from other biological systems.
Keywords
ACCDLPFCECT5HTDMNDBSDTIγ-aminobutyric acidElectroencephalographydeep brain stimulationdiffusion tensor imagingfMRIfunctional magnetic resonance imagingElectroconvulsive therapyCognitive-behavioural therapyCBTSerotonindefault mode networkhigh frequencyanterior cingulate cortexdorsolateral prefrontal cortexCSFCerebrospinal fluidEnigmafractional anisotropyEEGGABA
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
Trehani M. Fonseka, Glenda M. MacQueen, Sidney H. Kennedy,